Yellow Fever Outbreak, Imatong, Southern Sudan

• Main Authors: Clayton O. Onyango, Victor O. Ofula, Rosemary C. Sang, Samson L. Konongoi, Abdourahmane Sow, Kevin M. De Cock, Peter M. Tukei, Fredrick A. Okoth, Robert Swanepoel, Felicity J. Burt, Norman C. Waters, Rodney L. Coldren
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2004-06-01
• Series: Emerging Infectious Diseases
• Subjects: Yellow fever; ELISA; Oligonucleotide primer; amplicon; nucleotide sequence; Sudan
• Online Access: https://wwwnc.cdc.gov/eid/article/10/6/03-0738_article

In May 2003, the World Health Organization received reports about a possible outbreak of a hemorrhagic disease of unknown cause in the Imatong Mountains of southern Sudan. Laboratory investigations were conducted on 28 serum samples collected from patients in the Imatong region. Serum samples from 13 patients were positive for immunoglobulin (Ig) M antibody to flavivirus, and serum samples from 5 patients were positive by reverse transcription–polymerase chain reaction with both the genus Flavivirus reactive primers and yellow fever virus–specific primers. Nucleotide sequencing of the amplicons obtained with the genus Flavivirus oligonucleotide primers confirmed yellow fever virus as the etiologic agent. Isolation attempts in newborn mice and Vero cells from the samples yielded virus isolates from five patients. Rapid and accurate laboratory diagnosis enabled an interagency emergency task force to initiate a targeted vaccination campaign to control the outbreak.